Generation and characterization of induced pluripotent stem cell (iPSC) line (JUCTCi002-A) from a patient with ataxia with oculomotor apraxia type 1 (AOA1) harboring a homozygous mutation in the APTX gene

Nidaa A. Ababneh(University of Jordan), Abdalla Awidi(University of Jordan), Raghda Barham(University of Jordan), Ban Al-Kurdi(University of Jordan), Duaa Abuarqoub(University of Jordan), Ahmad M. Altantawi(University of Jordan), Abdulla Alzibdeh(University of Jordan), Dema Ali(University of Jordan), Basil Sharrack(Sheffield Teaching Hospitals NHS Foundation Trust), Asim Khanfar(University of Jordan), Abdee T. Ryalat(King Hussein Cancer Center)
Stem Cell Research
July 25, 2020
10.1016/j.scr.2020.101925
Cited by 6

Related Papers

siRNA: Mechanism of action, challenges, and therapeutic approaches
|European Journal of Pharmacology|2021|428
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
|The Lancet|2008|276
<i>C9orf72</i> Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
|Stem Cells|2016|248
Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study
|Journal of Orthopaedic Surgery and Research|2017|141
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy
|CNS Neuroscience & Therapeutics|2017|123